These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16374459)

  • 1. Regulation of skin microvasculature angiogenesis, cell migration, and permeability by a specific inhibitor of PKCalpha.
    Bokhari SM; Zhou L; Karasek MA; Paturi SG; Chaudhuri V
    J Invest Dermatol; 2006 Feb; 126(2):460-7. PubMed ID: 16374459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells.
    Koivunen J; Aaltonen V; Koskela S; Lehenkari P; Laato M; Peltonen J
    Cancer Res; 2004 Aug; 64(16):5693-701. PubMed ID: 15313909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.
    Xu H; Czerwinski P; Hortmann M; Sohn HY; Förstermann U; Li H
    Cardiovasc Res; 2008 May; 78(2):349-55. PubMed ID: 18056764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cα/β inhibitor Gö6976 promotes PC12 cell adhesion and spreading through membrane recruitment and activation of protein kinase Cδ.
    Jung SY; Kim OB; Kang HK; Jang DH; Min BM; Yu FH
    Exp Cell Res; 2013 Feb; 319(3):153-60. PubMed ID: 23063429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
    Liu Q; Chen X; Macdonnell SM; Kranias EG; Lorenz JN; Leitges M; Houser SR; Molkentin JD
    Circ Res; 2009 Jul; 105(2):194-200. PubMed ID: 19556521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VCAM-1 signals activate endothelial cell protein kinase Calpha via oxidation.
    Abdala-Valencia H; Cook-Mills JM
    J Immunol; 2006 Nov; 177(9):6379-87. PubMed ID: 17056569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production.
    Okazaki J; Mawatari K; Liu B; Kent KC
    Surgery; 2000 Aug; 128(2):192-7. PubMed ID: 10922991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway.
    Desai TR; Leeper NJ; Hynes KL; Gewertz BL
    J Surg Res; 2002 May; 104(2):118-23. PubMed ID: 12020130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.
    Aaltonen V; Peltonen J
    Anticancer Res; 2010 Oct; 30(10):3995-9. PubMed ID: 21036713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
    Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
    Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
    Wu TT; Hsieh YH; Hsieh YS; Liu JY
    J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration of retinal pigment epithelium cells is regulated by protein kinase Cα in vitro.
    Qiu S; Jiang Z; Huang Z; Chen X; Qian X; Gao Q; Zheng H
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7082-90. PubMed ID: 24084091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of PKCα in isoenzyme-selective regulation of cardiac transient outward current Ito and Kv4.3 channels.
    Scholz EP; Welke F; Joss N; Seyler C; Zhang W; Scherer D; Völkers M; Bloehs R; Thomas D; Katus HA; Karle CA; Zitron E
    J Mol Cell Cardiol; 2011 Nov; 51(5):722-9. PubMed ID: 21803046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cbeta isoform down-regulates the expression of MDR3 P-glycoprotein in human Chang liver cells.
    Suzuki S; Hayashi H; Takagi K; Kondo T; Takagi K; Ueyama J; Wakusawa S
    Biochim Biophys Acta; 2006 Oct; 1760(10):1552-7. PubMed ID: 16854530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
    Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
    Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKCα suppresses osteoblastic differentiation.
    Nakura A; Higuchi C; Yoshida K; Yoshikawa H
    Bone; 2011 Mar; 48(3):476-84. PubMed ID: 20951242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis.
    Rothmeier AS; Ischenko I; Joore J; Garczarczyk D; Fürst R; Bruns CJ; Vollmar AM; Zahler S
    FASEB J; 2009 Apr; 23(4):1127-37. PubMed ID: 19056838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
    Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
    Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.